例如荷商葛兰素史克药厂(GSK)预防脑膜炎(Meningitis C)的NeisVac-C疫苗技术就是在NRC生技计画下的生物科学研究中心(Institute for Biological Sciences)所研发出来的。
基于1个网页-相关网页
Meningitis is relatively rare but extremely serious and universities advise students to be immunised against meningitis C, following outbreaks on a number of UK campuses in recent years.
脑膜炎是相当罕见而非常严重的疾病。 由于近来年在英国大学里爆发过数起脑膜炎疾病,大学往往建议学生打脑膜炎疫苗以抵抗脑膜炎。
A heptavalent vaccine protecting against meningitis A and C was licensed in 2007.
预防甲型和丙型脑膜炎的七价疫苗于2007年获得许可。
A tetravalent meningococcal meningitis vaccine (licensed in the United States) and a heptavalent vaccine protecting against meningitis A and C (to be licensed in 2007);
一种四价流行性脑脊髓膜炎疫苗(已在美利坚合众国获许可证)和一种预防脑膜炎A和C的七价疫苗(将于2007年注册);
应用推荐